NCT03542513View on ClinicalTrials.gov

First-void Urine Samples for the Follow-up of Women Treated for High-grade Cervical Intraepithelial Neoplasia (CIN)

CompletedOBSERVATIONAL
Enrollment

65

Participants

Timeline

Start Date

October 30, 2017

Primary Completion Date

December 12, 2022

Study Completion Date

September 25, 2024

Conditions
Cervical Cancer
Interventions
DEVICE

Colli-Pee

Urine samples will be collected with the Colli-Pee device (Novosanis NV, Wijnegem, Belgium).

DEVICE

Qvintip

Vaginal self-samples will be collected with the Qvintip (Aprovix AB, Uppsala, Sweden).

Trial Locations (1)

2610

University of Antwerp - Centre for the Evaluation of Vaccination, Wilrijk

All Listed Sponsors
collaborator

University Hospital, Antwerp

OTHER

lead

Universiteit Antwerpen

OTHER

NCT03542513 - First-void Urine Samples for the Follow-up of Women Treated for High-grade Cervical Intraepithelial Neoplasia (CIN) | Biotech Hunter | Biotech Hunter